“[…] Pfizer is widely perceived to be at the top of the tree, Moderna and Johnson & Johnson just beneath that, followed by Oxford AstraZeneca, Sinopharm and Sputnik. I don’t know the extent to which this is driving decision-making, but I’ve heard several people say that they’re prepared to wait …
Read More »